LA JOLLA, Calif.--(BUSINESS WIRE)--Jan. 10, 2006--Ventegra,(SM) focused on the delivery of pharmaceutical services that make paramount both transparency and flexibility, today announced the appointment of Alexander M. Gilderman, Pharm.D., as Vice President, Clinical Programs. Robert Taketomo, Pharm.D, President and CEO, Ventegra, says, “Dr. Gilderman brings a stellar background of clinical expertise to Ventegra. We are most fortunate to have a professional of his caliber at the helm of our Clinical Program.”
